Murine systemic lupus erythematosus (SLE) manifests several autoimmune perturbations that resemble human SLE, including cytokine aberrations, lymphoproliferation, hypergammaglobulinemia, autoantibody formation, and immune complex glomerulonephritis. In multiple studies, elevated serum prolactin concentrations (hyperprolactinemia) stimulated appearance or progression of murine lupus. Autoimmune disease acceleration by prolactin appears to be accentuated by estrogen stimulation of prolactin secretion and independent of immunosuppressive effects of androgens such as testosterone. Conversely, suppression of serum prolactin concentrations by bromocriptine inhibits development of murine SLE. These data clearly support the concept that prolactin is immunostimulatory in autoimmune disease and that the therapeutic goal of lowering serum prolactin concentrations may be beneficial to patients. Further utilization of murine SLE models will facilitate dissection of the actions and interactions of prolactin with estrogen, progesterone and testosterone and lead to a better understanding of hormonal immunomodulation and therapy of autoimmune disease.
Theofilopoulos AN . Murine models of lupus. In: Lahita RG (ed). Systemic Lupus Erythematosus, 2nd edn.Churchill Livingstone: New York , 1992, pp 121–194.
2.
Steinberg AD , Melez KA , Raveche ES et al. Approach to the study of the role of sex hormones in autoimmunity . Arthritis Rheum1979; 22: 1170–1187 .
3.
Roubinian JN , Talal PK , Siiteri JA , Sadakian JA . Sex hormone modulation of autoimmunity in NZB/NZW mice . Arthritis Rheum1979; 22: 1162–1169 .
4.
Frantz AG . Prolactin . New Engl J Med1978; 298: 201–206 .
5.
Franks S.Regulation of prolactin secretion by oestrogens: physiological and pathological significance . Clin Sci1983; 65: 457–462 .
6.
Wilson JD , Foster DW (eds). Williams' Textbook of Endocrinology, 8th edn.WB Saunders: Philadelphia, PA , 1992
7.
Parkes D.Bromocriptine . New Engl J Med1979; 301: 873–878 .
8.
Adler RA . The anterior pituitary grafted rat: a valid model of chronic hyperprolactinemia . Endocrinol Rev1986; 7: 302–313 .
9.
McMurray R , Keisler D , Kanuckel K , Izui S , Walker SE . Prolactin influences autoimmune disease activity in the female B/W mouse . J Immunol1991; 147: 3780–3787 .
10.
Neidhart M.Bromocriptine has little direct effect on murine lymphocytes, the immunomodulatory effect being mediated by the suppression of prolactin secretion . Biomed Pharmacother1997; 51: 118–125 .
11.
Blank M , Krause I , Buskila D et al. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells . Cell Immunol1995; 162: 114–122 .
12.
McMurray RW , Weidensaul D , Allen SH , Walker SE . Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus . J Rheumatol1995; 22: 2084–2091 .
13.
Alvarez-Nemegyei J , Cobarrubias-Cobos A , Escalante-Triay F , Sosa-Munoz J , Miranda JM , Jara LJ . Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study . Lupus1998; 7: 414–419 .
14.
Walker SE , Reddy GH , Miller D et al. Treatment of active systemic lupus erythematosus (SLE) with the prolactin lowering drug bromocriptine: comparison with hydroxychloroquine in a randomized, blinded one-year study . Arthritis Rheum1999; 42(Suppl 9): S282-S282 .
15.
Morikawa K , Oseko F , Morikawa S . Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro . Clin Exp Immunol1994; 95: 514–518 .
16.
Morikawa K , Oseko F , Morikawa S . Immunosuppressive property of bromocriptine on human B lymphocyte function in vitro . Clin Exp Immunol1993; 93: 200–205 .
17.
Nagafuchi H , Suzuki N , Kaneko A , Asai T , Sakane T . Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis . J Rheumatol1999; 26: 1890–1900 .
18.
Nagy E , Berczi I , Wren GE , Asa SL , Kovacs K . Immunomodulation by bromocriptine . Immunopharmacology1983; 6: 231–243 .
19.
McMurray R , Keisler D , Izui S , Walker SE . Hyperprolactinemia in male NZB/NZW (B/W) F1 mice: accelerated autoimmune disease with normal circulating testosterone . Clin Immunol Immunopathol1994; 71: 338–343 .
20.
McMurray RW , Keisler D , Izui S , Walker SE . Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus . J Rheumatol1993; 20: 1143–1151 .
21.
Ratkay LG , Weinberg J , Waterfyeld JD . The effect of lactation in the post-partum arthritis of MRL-lpr/fas mice . Rheumatology (Oxford)2000; 39: 646–651 .
22.
Mattsson R , Mattsson A , Holmdahl R , Whyte A , Rook GA . Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis . Clin Exp Immunol1999; 85: 41–47 .
23.
Walker SE , McMurray RW , Besch-Williford CL , Keisler DH . Premature death with bladder outlet obstruction and hyperprolactinemia in New Zealand blackNew Zealand white mice treated with ethinyl estradiol and 17 beta-estradiol . Arthritis Rheum1992; 35: 1387–1392 .
24.
Cross RJ , Campbell JL , Roszman TL . Potentiation of antibody responsiveness after the transplantation of syngeneic pituitary gland . J Neuroimmunol1989; 25: 29–35 .
25.
McMurray RW . Estrogen, prolactin, and autoimmunity: actions and interactions . Int Immunopharmac2001; 1: 995–1008 .
26.
Carlsten H , Tarkowski A , Holmdahl R , Nilsson LA . Oestrogen is a potent disease accelerator in SLE-prone MRL/lpr/lpr mice . Clin Exp Immunol1990; 80: 467–473 .
27.
Holmdahl R , Carelsten H , Jansson L , Larsson P . Oestrogen is a potent immunomodulator of murine experimental rheumatoid disease . Br J Rheumatol1989; 28(Suppl 1): 54–58 .
28.
Carlsten H , Holmdahl R , Tarkowski A , Nilsson LA . Oestradiol suppression of delayed type hypersensitivity in autoimmune (NZB/NZW) F1 mice is a trait inherited from the healthy NZW parental strain . Immunology1989; 67: 205–209 .
29.
Carlsten H , Nilsson N , Jonsson R , Tarkowski A . Differential effects of oestrogen in murine lupus: acceleration of glomerulonephritis and amelioration of T cell mediated lesions . J Autoimmunity1991; 4: 845–856 .
30.
Elbourne KB , Keisler D , McMurray RW . Differential effects of estrogen and prolactin on autoimmune disease in the NZB/NZW F1 mouse model of systemic lupus erythematosus . Lupus1998; 7: 420–427 .
31.
Jansson L , Olson T , Holmdahl R . Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice . J Neuroimmunol1994; 53: 203–207 .
32.
Carlsten H , Verdrengh M , Taube M . Additive effects of suboptimal doses of estrogen and cortisone on the suppression of T lymphocyte dependent inflammatory responses in mice . Inflamm Res1996; 45: 26–30 .
33.
Whyte A , Williams RO . Bromocriptine suppresses postpartum exacerbation of collagen-induced arthritis . Arthritis Rheum1988; 31: 927–928 .
34.
Peeva E , Griwaldi C , Spatz L , Diamond B . Bromocriptine restores tolerance in estrogen-treated mice . J Clin Invest2000; 106: 1373–1379 .
35.
Jara-Quezada L , Graef A , Lavalle C . Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus . J Rheumatol1991; 18: 349–353 .
36.
Confavreux C , Hutchinson M , Hours MM , Cortinovis-Tourniaire P , Moreau T . Rate of pregnancy-related relapse in multiple sclerosis . Pregnancy in Multiple Sclerosis Group. [see comments]. New Engl J Med1998; 339: 285–291 .
37.
Barrett JH , Brennan P , Fiddler M , Silman A . Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis . Arthritis Rheum2000; 43: 1010–1015 .
38.
Formby B.Immunologic response in pregnancy . Endocrinol Metab Clin N Am1995; 24: 187–205 .
